- Документjamaneurology_mendell_2021_oi_210023_1624467431.00495загружено:
alvaro.bosch.ibanez
- Документinformeзагружено:
alvaro.bosch.ibanez
- Документinforme (1)загружено:
alvaro.bosch.ibanez
- Документinforme (2)загружено:
alvaro.bosch.ibanez
- ДокументAtrofia_muscular_espinalзагружено:
alvaro.bosch.ibanez
- ДокументGil Lizarraga, Uxueзагружено:
alvaro.bosch.ibanez
- ДокументSpinal Muscular Atrophyзагружено:
alvaro.bosch.ibanez
- ДокументSafety and efficacy of nusinersen in spinal muscular atrophy The EMBRACE studyзагружено:
alvaro.bosch.ibanez
- ДокументSpinal muscular atrophy From approved therapies to future therapeutic targets for personalized medicineзагружено:
alvaro.bosch.ibanez
- ДокументNew and Developing Therapies in Spinal Muscularзагружено:
alvaro.bosch.ibanez
- ДокументExpert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophyзагружено:
alvaro.bosch.ibanez
- ДокументFive-Year Extension Results of the Phase 1 START Trialзагружено:
alvaro.bosch.ibanez
- ДокументAdvances and limitations for the treatment of spinal muscular atrophyзагружено:
alvaro.bosch.ibanez